Recombinant interleukin 2 for metastatic renal cell carcinoma in haemodialysis patients

Eur J Cancer. 1992;28A(10):1770-1. doi: 10.1016/0959-8049(92)90092-g.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Carcinoma, Renal Cell / secondary*
  • Humans
  • Injections, Subcutaneous
  • Interleukin-2 / adverse effects*
  • Kidney Neoplasms / pathology*
  • Male
  • Middle Aged
  • Recombinant Proteins / adverse effects
  • Renal Dialysis

Substances

  • Interleukin-2
  • Recombinant Proteins